Navigation Links
R. Kerry Clark and Robert J. Palmisano Join Bausch & Lomb Board of Directors
Date:9/23/2009

ROCHESTER, N.Y., Sept. 23 /PRNewswire/ -- Bausch & Lomb, the global eye health company, today announced R. Kerry Clark and Robert J. Palmisano have joined its board of directors.

"We are adding two outstanding business leaders with broad and relevant experience," said Gerald M. Ostrov, chairman and chief executive officer, Bausch & Lomb. "Choices like these help us become better positioned for long-term growth. We welcome Kerry and Bob and look forward to benefiting from their unique backgrounds and expertise."

Mr. Clark retired in September 2009 as chairman and chief executive officer of Cardinal Health, Inc. (NYSE: CAH), a Fortune 20 company. Under his leadership, Cardinal Health acquired numerous medical technologies that helped the company expand its service to hospitals, pharmacies and clinicians across the United States. Before his leadership at Cardinal Health, Mr. Clark spent more than 30 years at Procter & Gamble Co., where he last served as vice chairman of the board. Mr. Clark is currently a director of Textron, General Mills and Hauser Capital Partners. He holds a bachelor's degree from Queens University.

Mr. Palmisano is the president, chief executive officer and director of ev3 Inc. (Nasdaq: EVVV), a leading global provider of technology for treating peripheral vascular disease and neurovascular diseases. Prior to ev3, Mr. Palmisano was president and chief executive officer for IntraLase Corp., which designed and developed laser products for vision correction, until IntraLase was acquired by Advanced Medical Optics, Inc. He also served as president and chief executive officer for pharmaceuticals firm MacroChem Corporation and Summit Autonomous, Inc., a global medical products company later acquired by Alcon, Inc. Mr. Palmisano has a long history with Bausch & Lomb, holding various executive positions within the company from 1985 to 1996. His last role with Bausch & Lomb was as senior vice president and president of its eyewear division. He holds a bachelor's degree from Providence College.

Mr. Clark and Mr. Palmisano join board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC; D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe; Richard Wallman, retired chief financial officer, Honeywell International, Inc.; and Gerald M. Ostrov.

About Bausch & Lomb

Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
2. Kerry Extends, Improves Small Business Innovation Program
3. Kerry, Snowe Push Finance Committee on Small Business Health Care
4. Sens. Kerry, Boxer and Feinstein call on FDA to Establish Maximum Level for Lead in Lipstick
5. National Press Club to Host NEWSMAKER Media Briefing on Improving the Cost of Healthcare with R. Kerry Clark
6. Kerry Teel Named President of Premier Anesthesia
7. Senate Passes Senator Kennedys Historic Bill to Regulate Tobacco Products; Senator Kerry Votes to Protect Americas Kids From Tobacco
8. Bob Woodruff, SGM (ret) Colin Rich and Senator John Kerry honored at IBMISPS Annual Awards
9. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
10. General Wesley K. Clark (Ret.) to Address Home Care Professionals
11. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: